ICAM1 and hepatocellular carcinoma: When specifically analyzing the association between the selected genes and immunotherapeutic efficacy in NSCLC and HCC, there was non-significant (except for ICAM1 in HCC) due to the limited sample number (n = 21 in NSCLC and n = 22 in HCC, Fig. 1C, D).